Novavax, Inc.
Novavax to Host Conference Call to Discuss Second Quarter 2014 Financial Results on August 6, 2014
DGAP-News: Novavax, Inc. 30.07.2014 / 22:10 --------------------------------------------------------------------- ROCKVILLE, Md., 2014-07-30 22:10 CEST (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, announced today that it will report its financial results for the second quarter of 2014 on Wednesday, August 6, 2014, after market close. In addition, management will host a conference call, to discuss the quarterly financial results and provide an update on corporate activities. Conference call details are as follows: Date: August 6, 2014 Time: 4:30 PM US eastern time Dial-in number: 1 (877) 212-6076 (domestic) or 1 (707) 287-9331 (international) Via Web: www.novavax.com Conference call Replay: Dates: Starting at 6:31pm on August 6, 2014 until midnight October 6, 2014 Dial-in number: 1 (855) 859-2056 (domestic) or 1 (404) 537-3406 (international) Passcode: 82216889 Via-Web: www.novavax.com, 'Investor Info'/'Events' About Novavax Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biopharmaceutical company creating novel vaccines and vaccine adjuvants to address a broad range of infectious diseases worldwide. Using innovative proprietary recombinant protein nanoparticle vaccine technology, the company produces vaccine candidates to efficiently and effectively respond to both known and newly emergent diseases. Additional information about Novavax is available on the company's website, novavax.com. CONTACT: Barclay Phillips SVP, Chief Financial Officer and Treasurer Novavax, Inc. 240-268-2000 News Source: NASDAQ OMX --------------------------------------------------------------------- 30.07.2014 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: Novavax, Inc. United States ISIN: US6700021040 End of News DGAP News-Service --------------------------------------------------------------------- 280104 30.07.2014
Aktuelle News
Aktuelle Berichte
Keine Berichte gefunden
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden